FI105256B - Menetelmä verenkorvikkeena käytettäväksi tarkoitetun koostumuksen valmistamiseksi - Google Patents

Menetelmä verenkorvikkeena käytettäväksi tarkoitetun koostumuksen valmistamiseksi Download PDF

Info

Publication number
FI105256B
FI105256B FI922937A FI922937A FI105256B FI 105256 B FI105256 B FI 105256B FI 922937 A FI922937 A FI 922937A FI 922937 A FI922937 A FI 922937A FI 105256 B FI105256 B FI 105256B
Authority
FI
Finland
Prior art keywords
hemoglobin
solution
adenosine
atp
blood
Prior art date
Application number
FI922937A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI922937A0 (fi
FI922937A (fi
Inventor
Mario Feola
Jan S Simoni
Peter C Canizaro
Original Assignee
Univ Texas Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas Tech filed Critical Univ Texas Tech
Publication of FI922937A0 publication Critical patent/FI922937A0/fi
Publication of FI922937A publication Critical patent/FI922937A/fi
Application granted granted Critical
Publication of FI105256B publication Critical patent/FI105256B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/805—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/41—Porphyrin- or corrin-ring-containing peptides
    • A61K38/42—Haemoglobins; Myoglobins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
FI922937A 1989-12-29 1992-06-24 Menetelmä verenkorvikkeena käytettäväksi tarkoitetun koostumuksen valmistamiseksi FI105256B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US45907189A 1989-12-29 1989-12-29
US45907189 1989-12-29
PCT/US1990/007442 WO1991009615A1 (en) 1989-12-29 1990-12-12 Polyhemoglobin stabilized by purine derivatives and glutathione
US9007442 1990-12-12

Publications (3)

Publication Number Publication Date
FI922937A0 FI922937A0 (fi) 1992-06-24
FI922937A FI922937A (fi) 1992-06-24
FI105256B true FI105256B (fi) 2000-07-14

Family

ID=23823294

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922937A FI105256B (fi) 1989-12-29 1992-06-24 Menetelmä verenkorvikkeena käytettäväksi tarkoitetun koostumuksen valmistamiseksi

Country Status (15)

Country Link
EP (1) EP0507870B1 (ko)
JP (1) JP2954347B2 (ko)
KR (1) KR0168866B1 (ko)
AT (1) ATE136466T1 (ko)
AU (1) AU650439B2 (ko)
CA (1) CA2072081C (ko)
DE (1) DE69026513T2 (ko)
DK (1) DK0507870T3 (ko)
ES (1) ES2086532T3 (ko)
FI (1) FI105256B (ko)
GR (1) GR3019775T3 (ko)
IE (1) IE73248B1 (ko)
NO (1) NO309799B1 (ko)
PT (1) PT96398B (ko)
WO (1) WO1991009615A1 (ko)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5650388A (en) * 1989-11-22 1997-07-22 Enzon, Inc. Fractionated polyalkylene oxide-conjugated hemoglobin solutions
ATE173273T1 (de) * 1991-02-12 1998-11-15 Univ Texas Tech Verbesserter blutersatz
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5900477A (en) * 1992-01-30 1999-05-04 Baxter International, Inc. Use of hemoglobin in the treatment of hemorrhagic shock
US5264555A (en) * 1992-07-14 1993-11-23 Enzon, Inc. Process for hemoglobin extraction and purification
US6242417B1 (en) * 1994-03-08 2001-06-05 Somatogen, Inc. Stabilized compositions containing hemoglobin
US5631219A (en) * 1994-03-08 1997-05-20 Somatogen, Inc. Method of stimulating hematopoiesis with hemoglobin
WO1996032130A1 (en) * 1995-04-10 1996-10-17 Baxter International Inc. The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
US5741894A (en) * 1995-09-22 1998-04-21 Baxter International, Inc. Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
DE60022751T2 (de) * 1999-07-01 2006-07-13 Sysmex Corp. Mittel zur stabilisierung von hämoglobinen
CN116941603A (zh) * 2023-07-21 2023-10-27 浙江康嘉基因技术有限公司 一种新型醛化鸡红细胞的制备方法及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4061736A (en) * 1975-02-02 1977-12-06 Alza Corporation Pharmaceutically acceptable intramolecularly cross-linked, stromal-free hemoglobin
US4401652A (en) * 1980-12-31 1983-08-30 Allied Corporation Process for the preparation of stroma-free hemoglobin solutions
US4473496A (en) * 1981-09-14 1984-09-25 The United States Of America As Represented By The Secretary Of The Army Intramolecularly crosslinked hemoglobin
US4831012A (en) * 1984-03-23 1989-05-16 Baxter International Inc. Purified hemoglobin solutions and method for making same
GB8710598D0 (en) * 1987-05-05 1987-06-10 Star Medical Diagnostics Ltd Hemoglobin based blood substitute
US4876241A (en) * 1987-05-22 1989-10-24 Armour Pharmaceutical Company Stabilization of biological and pharmaceutical products during thermal inactivation of viral and bacterial contaminants

Also Published As

Publication number Publication date
DE69026513T2 (de) 1996-09-12
AU650439B2 (en) 1994-06-23
PT96398B (pt) 1998-12-31
NO922551D0 (no) 1992-06-26
FI922937A0 (fi) 1992-06-24
GR3019775T3 (en) 1996-07-31
ATE136466T1 (de) 1996-04-15
JP2954347B2 (ja) 1999-09-27
AU7142591A (en) 1991-07-24
DK0507870T3 (da) 1996-06-10
IE904717A1 (en) 1991-07-17
FI922937A (fi) 1992-06-24
IE73248B1 (en) 1997-05-21
JPH05504766A (ja) 1993-07-22
CA2072081A1 (en) 1991-06-30
ES2086532T3 (es) 1996-07-01
WO1991009615A1 (en) 1991-07-11
EP0507870B1 (en) 1996-04-10
PT96398A (pt) 1991-10-31
KR0168866B1 (ko) 1999-01-15
CA2072081C (en) 2002-07-30
NO309799B1 (no) 2001-04-02
NO922551L (no) 1992-08-28
KR920703087A (ko) 1992-12-17
EP0507870A4 (en) 1993-08-11
DE69026513D1 (de) 1996-05-15
EP0507870A1 (en) 1992-10-14

Similar Documents

Publication Publication Date Title
US5439882A (en) Blood substitute
US5296465A (en) Ultra pure hemoglobin solutions and blood-substitutes
JP2983544B2 (ja) 非細胞性赤血球代替品
EP0277289B2 (en) Extra pure semi-synthetic blood substitute
KR100964604B1 (ko) 산소 친화도가 높은 개질된 헤모글로빈을 포함하는 산소 전달용 조성물 및 방법
ZA200505814B (en) Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing
FI105256B (fi) Menetelmä verenkorvikkeena käytettäväksi tarkoitetun koostumuksen valmistamiseksi
JP4581110B2 (ja) ヘモグロビンの精製方法
CA2250274C (en) Method and apparatus for preparing an acellular red blood cell substitute
FI106362B (fi) Menetelmä verenkorvikkeena käytettäväksi soveltuvan koostumuksen valmistamiseksi
KR100562762B1 (ko) 무세포성적혈구대체물을제조하기위한방법및장치